Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations

被引:36
|
作者
Sachana, Magdalini [1 ]
Shafer, Timothy J. [2 ]
Terron, Andrea [3 ]
机构
[1] Org Econ Cooperat & Dev, Environm Hlth & Safety Div, 2 Rue Andre Pascal, F-75775 Paris 16, France
[2] US EPA, Rapid Assay Dev Branch, Biomol & Computat Toxicol Div, Ctr Computat Toxicol & Exposure MD B105 03, Durham, NC 27711 USA
[3] European Food Safety Author, PREV Unit, I-43126 Parma, Italy
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 02期
关键词
developmental neurotoxicity; in vitro battery; integrated approaches to testing and assessment; adverse outcome pathways;
D O I
10.3390/biology10020086
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary It is recognized that the current developmental neurotoxicity (DNT) testing paradigm is not fit-for -purpose for the assessment of a large number of chemicals. In the last two decades there have been scientific advances made for evaluating chemical interactions with the developing nervous system that rely on alternative to animal methods. The Organisation for Economic Co-Operation and Development (OECD) provides a forum to develop internationally harmonised guidance to test and assess chemicals for DNT that is primarily based on cellular models. Given the complexity of the developing nervous system and the availability of a number of non-animal methods to address DNT, integration of data from multiple studies is necessary and an OECD framework for organising existing scientific knowledge can be applied as the canvas of this integration. Herein, we provide a brief overview of the OECD DNT project and summarize various achievements of relevance to the project. The review also presents an opportunity to describe considerations for uptake of the DNT non animal methods in a regulatory context. Characterization of potential chemical-induced developmental neurotoxicity (DNT) hazard is considered for risk assessment purposes by many regulatory sectors. However, due to test complexity, difficulty in interpreting results and need of substantial resources, the use of the in vivo DNT test guidelines has been limited and animal data on DNT are scarce. To address challenging endpoints such as DNT, the Organisation for Economic Co-Operation and Development (OECD) chemical safety program has been working lately toward the development of integrated approaches for testing and assessment (IATA) that rely on a combination of multiple layers of data (e.g., in vitro, in silico and non-mammalian in vivo models) that are supported by mechanistic knowledge organized according to the adverse outcome pathway (AOP) framework. In 2017, the OECD convened a dedicated OECD expert group to develop a guidance document on the application and interpretation of data derived from a DNT testing battery that relies on key neurodevelopmental processes and is complemented by zebrafish assays. This review will provide a brief overview of the OECD DNT project and summarize various achievements of relevance to the project. The review also presents an opportunity to describe considerations for uptake of the DNT in an in vitro battery in a regulatory context.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 20 条
  • [1] An improved approach to regulatory developmental neurotoxicity testing (DNT)
    Vorhees, Charles
    Williams, Michael
    NEUROTOXICOLOGY AND TERATOLOGY, 2018, 67 : 77 - 77
  • [2] Establishment of in vitro assays for regulatory developmental neurotoxicity testing
    Bartmann, K.
    Masjosthusmann, S.
    Stuerzl, L. -C.
    Waldmann, T.
    Leist, M.
    Fritsche, E.
    TOXICOLOGY LETTERS, 2019, 314 : S221 - S221
  • [3] Towards a regulatory use of alternative developmental neurotoxicity testing (DNT)
    Terron, Andrea
    Bennekou, Susanne Hougaard
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 354 : 19 - 23
  • [4] International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing
    Sachana, Magdalini
    Bal-Price, Anna
    Crofton, Kevin M.
    Bennekou, Susanne H.
    Shafer, Timothy J.
    Behl, Mamta
    Terron, Andrea
    TOXICOLOGICAL SCIENCES, 2019, 167 (01) : 45 - 57
  • [5] Advancing the Science of Developmental Neurotoxicity (DNT): Testing for Better Safety Evaluation
    Bal-Price, Anna K.
    Coecke, Sandra
    Costa, Lucio
    Crofton, Kevin M.
    Fritsche, Ellen
    Goldberg, Alan
    Grandjean, Philippe
    Lein, Pamela J.
    Li, Abby
    Lucchini, Roberto
    Mundy, William R.
    Padilla, Stephanie
    Persico, Antonio M.
    Seiler, Andrea E. M.
    Kreysa, Joachim
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2012, 29 (02) : 202 - 215
  • [6] OECD/EFSA Workshop on Developmental Neurotoxicity (DNT): The Use of Non-Animal Test Methods for Regulatory Purposes
    Fritsche, Ellen
    Crofton, Kevin M.
    Hernandez, Antonio F.
    Bennekou, Susanne Hougaard
    Leist, Marcel
    Bal-Price, Anna
    Reaves, Elissa
    Wilks, Martin F.
    Terron, Andrea
    Solecki, Roland
    Sachana, Magdalini
    Gourmelon, Anne
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2017, 34 (02) : 311 - 315
  • [7] Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes
    Fritsche, Ellen
    Grandjean, Philippe
    Crofton, Kevin M.
    Aschner, Michael
    Goldberg, Alan
    Heinonen, Tuula
    Hessel, Ellen V. S.
    Hogberg, Helena T.
    Bennekou, Susanne Hougaard
    Lein, Pamela J.
    Leist, Marcel
    Mundy, William R.
    Paparella, Martin
    Piersma, Aldert H.
    Sachana, Magdalini
    Schmuck, Gabriele
    Solecki, Roland
    Terron, Andrea
    Monnet-Tschudi, Florianne
    Wilks, Martin F.
    Witters, Hilda
    Zurich, Marie-Gabrielle
    Bal-Pric, Anna
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 354 : 3 - 6
  • [8] Regulatory developmental neurotoxicity testing: a model study focussing on conventional neuropathology endpoints and other perspectives
    de Groot, DMG
    Bos-Kuijpers, MHM
    Kaufmann, WSH
    Lammers, JHCM
    O'Callaghan, JP
    Pakkenberg, B
    Pelgrim, MTM
    Waalkens-Berendsen, IDH
    Waanders, MM
    Gundersen, HJJ
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2005, 19 (03) : 745 - 755
  • [9] International STakeholder NETwork (ISTNET) for Creating a Developmental Neurotoxicity Testing (DNT) Roadmap for Regulatory Purposes
    Crofton, Kevin
    Fritsche, Ellen
    Ylikomi, Timo
    Bal-Price, Anna
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2014, 31 (02) : 223 - 224
  • [10] Accelerating the paradigm shift toward inclusion of pregnant women in drug research: Ethical and regulatory considerations
    White, Amina
    SEMINARS IN PERINATOLOGY, 2015, 39 (07) : 537 - 540